AI Detects Heart Failure 6 Years Before Symptoms Using Multi-Omics Data
Machine learning model identifies HFpEF patients 6.3 years before symptom onset with 93% accuracy using integrated clinical and molecular data.
Cardiovascular health, heart failure, atherosclerosis, and cardiac research
254 articles
Machine learning model identifies HFpEF patients 6.3 years before symptom onset with 93% accuracy using integrated clinical and molecular data.
Natural isoflavone prevents cardiac enlargement through novel mitochondrial protection pathway, offering new therapeutic approach.
Breakthrough study shows one epigenetic factor can transform cardiac fibroblasts into heart muscle cells, improving function after myocardial infarction.
New research questions whether intravascular ultrasound is always necessary for evaluating left main coronary artery disease.
Breakthrough discovery of PAK1 kinase activators shows promise for treating cardiac hypertrophy and heart failure through targeted enzyme enhancement.
New research shows inhibiting fatty acid synthase prevents cardiac hypertrophy and restores heart function in multiple models.
Advanced cardiac MRI strain measurements identify diabetic patients at highest risk for heart failure hospitalization and death.
Comprehensive review reveals HRV's potential for early CVD detection, risk prediction, and personalized treatment monitoring.
Novel liposome therapy delivers miR-10a to atherosclerotic plaques, reprogramming inflammatory macrophages and reducing disease progression in mice.
Even equally fit athletes and HCM patients show distinct breathing efficiency patterns during exercise testing.
New review examines how VO2 max testing is transforming cardiovascular care and identifies critical gaps in clinical application.
New AI system achieves 92% accuracy in detecting heart murmurs using just a smartphone or digital stethoscope for home cardiac screening.